Published in Law and Health Weekly, March 26th, 2005
"Broadlane counts among its customers more than 830 acute care hospitals and more than 2,400 sub-acute care facilities," stated IRIS President and Chief Executive Officer Cesar Garcia.
"We are pleased that Broadlane will make our flagship iQ200 Automated Urine Chemistry Analyzer and iQ200 System readily available to a significant group of health care providers.
"Large group purchasing organizations such as Broadlane provide IRIS an ever-expanding market for the iQ200...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.